Company intelligence / Profile preview
Transport Pharmaceuticals, Inc.
Framingham, Massachusetts, United States
- Ownership
- Private
- Development stage
- Other
01
Overview
In 2007, Transport Pharmaceuticals received the Frost & Sullivan North American Technology Innovation of the Year Award for its electrokinesis-enabled drug delivery platform. Its lead product was a novel topical acyclovir gel delivered via a microprocessor-driven device for self-administration in treating cold sores. No recent clinical results are available.
- Therapeutic areas
- Infectious Diseases
- Modalities
- Topical drug deliverycombination drug/device productselectrokinesis-enabled drug delivery
- Industry
- Biotech
02
Drug pipeline
1 assetBeyond the preview
Go deeper on Transport Pharmaceuticals, Inc..
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Clinical trials
Follow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Licensing & deals
Explore licensing agreements, acquisitions, and the assets behind each deal.
- Partners
- Deal terms
- Milestones
Funding history
Trace financing activity and the investors behind a company’s development.
- Funding rounds
- Investors
- Capital raised
Competitive landscape
Compare peer pipelines by target, modality, and therapeutic area.
- Peer companies
- Targets
- Pipeline overlap
Technologies & patents
Explore technology platforms and the patent landscape around relevant assets.
- Platforms
- Patents
- Assignees
Research & analysis
Connect company news and source material to the questions you’re investigating.
- Company news
- Sources
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on Transport Pharmaceuticals, Inc..